Discovery & Development Formulation, Contract Development Services, Small Molecules, Trends & Forecasts

Small Molecules: Expert Insights

In this eBook, thought leaders from Cambrex discuss market opportunities, drug development challenges, and more.

02/10/2021

sponsored by Cambrex

The small molecule drug development pipeline is booming! And with shrinking clinical trial cohorts (especially in oncology and orphan indications), smaller and virtual companies are now able to take candidates further than ever before. In this eBook, experts from Cambrex discuss the key trends affecting opportunities in the small molecule market – and some of the biggest drug development challenges. David Pearson explains the frustration that can accompany unexpected hydrates of an API, and Ralph N. Landau shares his thoughts on why the pharma industry must move away from a “one-size-fits-all” approach to pediatric formulations.

Click here to download the eBook

Email*

Choose a password*

I have read and understand the Privacy Notice *

Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

I want to stay up to date with the "Small Molecule" field I want to stay up to date with the Cell and Gene field I want to stay up to date with the Bioprocessing field

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.